Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily outperforming both the S&P...
With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to be looking for bargains all the...